Risk association of orofacial cleft and glucocorticoids exposure during pregnancy: a meta-analysis (GC_OC)

Study identification

• EU PAS number:
  EUPAS26922
• Study ID:
  33602
• Official title and acronym:
  Risk association of orofacial cleft and glucocorticoids exposure during pregnancy: a meta-analysis (GC_OC)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study status:
  Finalised

Research institutions and networks

Institutions

Bayer AG

Study timelines

Date when funding contract was signed

Planned: 02/07/2018

Actual: 02/07/2018

Study start date

Planned: 15/12/2018

Actual: 16/11/2018

Date of final study report

Planned: 28/02/2020

Actual: 28/11/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Bayer AG

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable